Ashburton Jersey Ltd lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 14.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 7,043 shares of the biotechnology company's stock after selling 1,170 shares during the period. Axon Enterprise accounts for 1.8% of Ashburton Jersey Ltd's portfolio, making the stock its 19th largest holding. Ashburton Jersey Ltd's holdings in Axon Enterprise were worth $4,186,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Alliancebernstein L.P. increased its holdings in shares of Axon Enterprise by 273.8% during the 4th quarter. Alliancebernstein L.P. now owns 1,109,045 shares of the biotechnology company's stock valued at $659,128,000 after acquiring an additional 812,337 shares during the last quarter. Norges Bank acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $482,081,000. GQG Partners LLC bought a new position in shares of Axon Enterprise in the fourth quarter valued at approximately $478,349,000. Groupama Asset Managment acquired a new stake in shares of Axon Enterprise in the third quarter worth $200,000. Finally, Vanguard Group Inc. boosted its holdings in shares of Axon Enterprise by 3.4% during the 4th quarter. Vanguard Group Inc. now owns 8,446,437 shares of the biotechnology company's stock worth $5,019,886,000 after buying an additional 275,959 shares during the period. Institutional investors own 79.08% of the company's stock.
Analysts Set New Price Targets
AXON has been the topic of a number of research reports. The Goldman Sachs Group boosted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a research report on Monday, January 27th. Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a report on Wednesday, February 19th. Needham & Company LLC reiterated a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, February 26th. TD Cowen started coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target for the company. Finally, JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus price target of $604.67.
Check Out Our Latest Stock Report on AXON
Axon Enterprise Price Performance
Shares of Axon Enterprise stock traded up $7.07 during trading on Friday, reaching $558.32. 157,690 shares of the company's stock were exchanged, compared to its average volume of 810,044. The firm's 50-day moving average price is $568.97 and its 200 day moving average price is $559.34. The company has a market cap of $42.78 billion, a P/E ratio of 144.27, a PEG ratio of 5.17 and a beta of 1.13. Axon Enterprise, Inc. has a 1-year low of $273.52 and a 1-year high of $715.99. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.
Insiders Place Their Bets
In other news, Director Jeri Williams sold 307 shares of the stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now directly owns 1,627 shares in the company, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 6.10% of the company's stock.
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles

Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.